Central Europe Online : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Central Europe Online .

Press releases published on September 2, 2026

Sep. 2, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire

Sep. 2, 2026

Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform

Indeterminate GlobeNewswire

Sep. 2, 2026

BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

A Previously Unattested Egyptian Title and a Face from Roman Egypt: TimeLine’s 8 September Auction

Indeterminate GlobeNewswire

Sep. 2, 2026

Das CFA Institute fordert einen stärkeren Anlegerschutz, da die EU den Zugang von Privatanlegern zu privaten Märkten ausweitet

Indeterminate GlobeNewswire

Sep. 2, 2026

Le CFA Institute appelle à un renforcement de la protection des investisseurs alors que l’UE élargit l’accès des investisseurs particuliers aux marchés privés

Indeterminate GlobeNewswire

Sep. 2, 2026

Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company

Indeterminate GlobeNewswire

Sep. 2, 2026

CoinShares Completes Acquisition of Bastion Asset Management

Indeterminate GlobeNewswire

Sep. 2, 2026

VEON to Release 3Q26 Earnings on November 6, 2026, Capital Markets Day Scheduled for November 16, 2026

Indeterminate GlobeNewswire

Sep. 2, 2026

Sitryx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Maze Therapeutics to Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

Indeterminate GlobeNewswire

Sep. 2, 2026

Verano Announces Upcoming Conference Participation

Indeterminate GlobeNewswire

Sep. 2, 2026

Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Indeterminate GlobeNewswire

Sep. 2, 2026

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 2, 2026

GoldInxs Announces Completion of Field Program at Millar Property in British Columbia’s Golden Triangle

Indeterminate GlobeNewswire

Sep. 2, 2026

Paramount Gold Announces BLM Approval of Plan of Operations and Determination of Financial Guarantee for the Grassy Mountain Project

Indeterminate GlobeNewswire

Sep. 2, 2026

easyMarkets Expands Commodity Offering with 24/7 Gold, Silver and Oil Trading

Indeterminate GlobeNewswire

Sep. 2, 2026

Resalis Therapeutics Appoints Diana M. Røpcke as Chief Medical Officer

Indeterminate GlobeNewswire